Biofund RVC's portfolio company National Bioservice opened a laboratory on November 23 in the Skolkovo Technopark. It has been the third laboratory by this company; the other two are located in St. Petersburg and Nizhny Novgorod.
The BioFund of RVC (Biopharmaceutical Investments of RVC LLC) increased its stake, from 54.44% to 69.48%, in PrimeBioMed, a research and production company which accumulates achievements in the field of molecular and cellular diagnostics.
An annual ranking of the activity of Russian venture capital funds from Firrma was published, which acts as a strategic partner of RVC partner — EY. According to the rating results, in 2016 the funds made 390 deals - a quarter more than in the previous year.
RVC Infrafund has performed a successful exit from the Chelyabinsk engineering company Regional Engineering Centre for Additive and Laser Technologies, CJSC (RIC AiLT).